Welcome to our dedicated page for Nephros news (Ticker: NEPH), a resource for investors and traders seeking the latest updates and insights on Nephros stock.
Nephros Inc (NEPH) specializes in advanced water purification systems and medical filtration technologies serving healthcare providers and commercial industries. This news hub provides investors and industry professionals with timely updates on operational milestones, product innovations, and strategic initiatives central to the company's mission of enhancing water safety.
Access the latest press releases covering Nephros' developments in hollow fiber filtration technology, regulatory achievements, and market expansions. Our curated collection includes earnings reports, partnership announcements, and updates on medical devices like mid-dilution hemodiafiltration systems designed for chronic renal care.
Key updates focus on advancements in medical water purification and commercial solutions addressing biofilm prevention and waterborne pathogens. Track developments in digital service models and filtration performance enhancements that impact both healthcare outcomes and industrial water management.
Bookmark this page for streamlined access to Nephros' evolving role in water technology. Check regularly for objective reporting on product certifications, executive leadership changes, and clinical trial progress relevant to long-term investors and sector analysts.
Nephros (NEPH) reported Q2 2024 financial results with net revenue of $3.3 million, an 8% decrease from Q2 2023. However, programmatic revenue increased by 8% year-over-year, driven by over 300 new accounts added in the past 12 months. The company reported a net loss of $0.3 million, an improvement from $0.4 million in Q2 2023. Adjusted EBITDA was ($133,000), compared to ($183,000) in the prior year.
CEO Robert Banks highlighted growth in the core programmatic business but noted a decline in emergency response sales. The company is developing new business models to address challenges in filter changeout schedules. As of June 30, 2024, Nephros had cash and cash equivalents of $3.1 million.
Nephros Inc (Nasdaq: NEPH), a leading water technology company, has announced its schedule for the second quarter 2024 financial results conference call. The company will file its Q2 financial results on Thursday, August 8, 2024 after market close and host a conference call at 4:30pm ET the same day. Participants can join the call using the following dial-in numbers:
- Domestic access: 1 (844) 808-7106
- International access: 1 (412) 317-5285
An audio archive will be available on the Nephros Investor Relations page shortly after the call. A replay will also be accessible until August 15, 2024, using specific replay access codes for domestic and international callers.
FAQ
What is the current stock price of Nephros (NEPH)?
What is the market cap of Nephros (NEPH)?
